Canary Wharf Group’s chief executive has said the “evolution” of the area which is diversifying beyond offices is well underway, after securing the green-light to develop a major new 23-storey life sciences building.
The landlord behind the Docklands financial district, working with developer Kadans Science Partner, has got planning approval for a 823,000 square feet tower than can provide workspace to a host of businesses including those in biotechnology, genomics and medical tech for example.
